Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hannah Mamuszka Insider Profile
4 Followers
Hannah Mamuszka, Director at BioNano Genomics, holds 65.79K shares in BioNano Genomics (Ticker: BNGO). Most recently, Hannah Mamuszka Bought $65,789 shares of BioNano Genomics on Jun 14, 2023 for an estimated value of 50.00K.
Hannah Mamuszka has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Hannah Mamuszka's holdings
Insider Roles
Director
Roles that Hannah Mamuszka holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Hannah Mamuszka
Hannah Mamuszka's Trading History
List of latest transactions for each holding click on a transaction to see Hannah Mamuszka's performance on stock
You May Also Like
Hannah Mamuszka insider profile FAQ
What is the percentage of profitable transactions made by Hannah Mamuszka?
The percentage of profitable transactions made by Hannah Mamuszka is ―.
What is the average return per transaction made by Hannah Mamuszka?
The average return per transaction made by Hannah Mamuszka is ―.
What stocks does Hannah Mamuszka hold?
Hannah Mamuszka holds: BNGO stocks.
What was Hannah Mamuszka’s latest transaction?
Hannah Mamuszka latest transaction was an Informative Buy of $50.00K.
What was Hannah Mamuszka's most profitable transaction?
Hannah Mamuszka’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Hannah Mamuszka's role in BioNano Genomics?
Hannah Mamuszka's role in BioNano Genomics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.